Atlas Trials

Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome

Clinical trial NCT02591199 · TERMINATED

Trial details

NCT number
NCT02591199
Sponsor
Urigen
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Interstitial CystitisBladder Pain Syndrome
Start date
2015-09-01
Primary completion
2018-05-14
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.